Balance Sheet Data
Crinetics Pharmaceuticals, Inc. (CRNX)
$16.17
-0.68 (-4.04%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 163.88 | 118.39 | 170.88 | 133.51 | 334.43 | 12,365.09 | 62,037.99 | 311,256.35 | 1,561,632.08 | 7,835,003.92 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 1.58 | 1.38 | 0 | 0 | 0 | 0.02 | 0.11 | 0.54 | 2.71 | 13.61 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.46 | 5.50 | 5.59 | 28.28 | 124.28 | 623.55 | 3,128.45 | 15,696.05 | 78,750.06 | 395,103.98 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -1.06 | -0.49 | -0.19 | -0.94 | -4.14 | -20.76 | -104.16 | -522.59 | -2,621.92 | -13,154.67 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.